In EL-4 T cells, MG-115 pretreatment had no effect on basal accessibility in nonstimulated cells. In P/I-stimulated cells, MG-115 reduced the increase in accessibility compared with cells without MG-115 pretreatment. In BSB8 cells, comparison of MG-115 with DMSO control showed that MG-115 failed to rescue T-Ag degradation even in cells overexpressing Bag3. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Basal accessibility in nonstimulated T cells
Cell-based study · EL-4 T cells [1]
EL-4 T cells were pretreated with MG-115. Treatment had no effect on the inherent basal level of accessibility in nonstimulated cells.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 μM
- Exposure duration
- pretreated for 1 h with the proteasome inhibitor MG115, then incubated with or without P/I for 4 h
- Method
- pretreated
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: MG-115
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Cell Culture and Preparation of Stable Cell Lines. (S7); Results > Remodeling of the GM-CSF Promoter Is Dependent on NF-κB Proteins. (S86, S87); Figure 4. legend (S172)
inherent basal level of accessibility seen in nonstimulated cells: inherent basal level of accessibility seen in nonstimulated cells; comparator: untreated — Results > Remodeling of the GM-CSF Promoter Is Dependent on NF-κB Proteins. (S87)
T antigen degradation in cells overexpressing Bag3
Cell-based study · BSB8 cells [2]
BSB8 cells were treated with MG-115 or DMSO control in a design involving a Bag3 expression plasmid. MG-115 failed to rescue T-Ag degradation even in cells overexpressing Bag3.
Literature-Reported Treatment Conditions
- Treatment concentration
- 30 µM
- Exposure duration
- At 24 hours post-transfections; Cells were treated for 24 hours
- Method
- treatment media
- Vehicle
- DMSO
- Co-treatment
- Other interventions in this design: expression plasmid encoding Bag3. Compound effect isolated by the comparison: MG-115 or DMSO (control).
Methods and source locations
Compound reported in the paper: MG-115
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Post-transcriptional Suppression of T-Ag by Bag3 is Independent from Proteasomal Pathway (S26); Materials and Methods > Inhibitors and Treatments (S90, S91); Figure 3 legend (S148, S149)
Western blot analysis was performed for the detection of Large T, and Bag3 proteins: Western blot analysis was performed for the detection of Large T, and Bag3 proteins; comparator: DMSO (control) — Results > Post-transcriptional Suppression of T-Ag by Bag3 is Independent from Proteasomal Pathway (S26); Figure 3 legend (S149)
Accessibility changes in stimulated T cells
Cell-based study · EL-4 T cells [1]
EL-4 T cells were untreated or pretreated with MG-115, then incubated with or without P/I. In P/I-stimulated cells, MG-115 reduced the increase in accessibility.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 μM
- Exposure duration
- pretreated for 1 h with the proteasome inhibitor MG115, then incubated with or without P/I for 4 h
- Method
- pretreated
- Co-treatment
- Other interventions in this design: PMA 20 ng/ml; calcium ionophore 1 μM. Compound effect isolated by the comparison: EL-4 T cells were either untreated or pretreated for 1 h with the proteasome inhibitor MG115, then incubated with or without P/I for 4 h..
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: MG-115
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Cell Culture and Preparation of Stable Cell Lines. (S6, S7); Materials and Methods > Chromatin Accessibility by Real-Time PCR. (S16, S17); Results > Remodeling of the GM-CSF Promoter Is Dependent on NF-κB Proteins. (S86, S88); Figure 4. legend (S172, S173, S174)
The percentage change in accessibility in 4 h P/I stimulated nuclei compared with nonstimulated nuclei: The percentage change in accessibility in 4 h P/I stimulated nuclei compared with nonstimulated nuclei; comparator: untreated — Results > Remodeling of the GM-CSF Promoter Is Dependent on NF-κB Proteins. (S88); Figure 4. legend (S174)